• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Criteria for Enrollment of Patients With COPD in Palliative Care Trials: A Systematic Review.COPD 患者参加姑息治疗试验的纳入标准:系统评价。
J Pain Symptom Manage. 2024 Jun;67(6):e891-e905. doi: 10.1016/j.jpainsymman.2024.01.028. Epub 2024 Jan 26.
2
Self-management interventions including action plans for exacerbations versus usual care in patients with chronic obstructive pulmonary disease.慢性阻塞性肺疾病患者自我管理干预措施(包括针对病情加重的行动计划)与常规护理的比较。
Cochrane Database Syst Rev. 2017 Aug 4;8(8):CD011682. doi: 10.1002/14651858.CD011682.pub2.
3
Action plans with brief patient education for exacerbations in chronic obstructive pulmonary disease.针对慢性阻塞性肺疾病急性加重的简短患者教育行动计划。
Cochrane Database Syst Rev. 2016 Dec 19;12(12):CD005074. doi: 10.1002/14651858.CD005074.pub4.
4
Prophylactic antibiotic therapy for chronic obstructive pulmonary disease (COPD).慢性阻塞性肺疾病(COPD)的预防性抗生素治疗
Cochrane Database Syst Rev. 2013 Nov 28(11):CD009764. doi: 10.1002/14651858.CD009764.pub2.
5
Chronic non-invasive ventilation for chronic obstructive pulmonary disease.慢性阻塞性肺疾病的慢性无创通气。
Cochrane Database Syst Rev. 2021 Aug 9;8(8):CD002878. doi: 10.1002/14651858.CD002878.pub3.
6
Assessing the comparative effects of interventions in COPD: a tutorial on network meta-analysis for clinicians.评估慢性阻塞性肺疾病干预措施的比较效果:面向临床医生的网状Meta分析教程
Respir Res. 2024 Dec 21;25(1):438. doi: 10.1186/s12931-024-03056-x.
7
Supported self-management for patients with moderate to severe chronic obstructive pulmonary disease (COPD): an evidence synthesis and economic analysis.中重度慢性阻塞性肺疾病(COPD)患者的支持性自我管理:证据综合与经济分析
Health Technol Assess. 2015 May;19(36):1-516. doi: 10.3310/hta19360.
8
Self-management interventions for people with chronic obstructive pulmonary disease.针对慢性阻塞性肺疾病患者的自我管理干预措施。
Cochrane Database Syst Rev. 2022 Jan 10;1(1):CD002990. doi: 10.1002/14651858.CD002990.pub4.
9
Comparison of the effectiveness of inhaler devices in asthma and chronic obstructive airways disease: a systematic review of the literature.吸入装置在哮喘和慢性阻塞性气道疾病中的有效性比较:文献系统评价
Health Technol Assess. 2001;5(26):1-149. doi: 10.3310/hta5260.
10
Prophylactic antibiotics for adults with chronic obstructive pulmonary disease: a network meta-analysis.慢性阻塞性肺疾病成人患者的预防性抗生素治疗:一项网络荟萃分析。
Cochrane Database Syst Rev. 2021 Jan 15;1(1):CD013198. doi: 10.1002/14651858.CD013198.pub2.

引用本文的文献

1
Early, integrated palliative care for people with chronic respiratory disease: lessons learnt from lung cancer.慢性呼吸道疾病患者的早期综合姑息治疗:从肺癌中汲取的经验教训
Ther Adv Respir Dis. 2025 Jan-Dec;19:17534666241305497. doi: 10.1177/17534666241305497.

本文引用的文献

1
European Respiratory Society clinical practice guideline: palliative care for people with COPD or interstitial lung disease.欧洲呼吸学会临床实践指南:COPD 或间质性肺疾病患者的姑息治疗。
Eur Respir J. 2023 Aug 17;62(2). doi: 10.1183/13993003.02014-2022. Print 2023 Aug.
2
Palliative Care Interventions in Advanced Chronic Obstructive Pulmonary Disease: An Integrative Review.晚期慢性阻塞性肺疾病的姑息治疗干预措施:综合评价。
J Palliat Med. 2023 Jun;26(6):856-866. doi: 10.1089/jpm.2022.0356. Epub 2023 Mar 1.
3
Project EPIC (Early Palliative Care In COPD): A Formative and Summative Evaluation of the EPIC Telehealth Intervention.项目 EPIC(慢性阻塞性肺疾病的早期姑息治疗):EPIC 远程医疗干预的形成性和总结性评估。
J Pain Symptom Manage. 2023 Apr;65(4):335-347.e3. doi: 10.1016/j.jpainsymman.2022.11.024. Epub 2022 Dec 7.
4
Palliative Care Early in the Care Continuum among Patients with Serious Respiratory Illness: An Official ATS/AAHPM/HPNA/SWHPN Policy Statement.严重呼吸系统疾病患者的照护延续链中的舒缓医疗:美国胸科学会/美国临终关怀与姑息医学学会/美国护士麻醉师协会/世界卫生组织姑息治疗联盟政策声明。
Am J Respir Crit Care Med. 2022 Sep 15;206(6):e44-e69. doi: 10.1164/rccm.202207-1262ST.
5
Impact of acute exacerbations of COPD on patients' health status beyond pulmonary function: A scoping review.COPD 急性加重对患者肺功能以外健康状况的影响:范围综述。
Pulmonology. 2023 Nov-Dec;29(6):518-534. doi: 10.1016/j.pulmoe.2022.04.004. Epub 2022 Jun 14.
6
ERS/ATS technical standard on interpretive strategies for routine lung function tests.ERS/ATS 技术标准:常规肺功能测试的解释策略。
Eur Respir J. 2022 Jul 13;60(1). doi: 10.1183/13993003.01499-2021. Print 2022 Jul.
7
Challenges Faced by Rural Primary Care Providers When Caring for COPD Patients in the Western United States.美国西部农村初级医疗服务提供者在照顾慢性阻塞性肺疾病(COPD)患者时面临的挑战。
Chronic Obstr Pulm Dis. 2021 Jul 28;8(3):336-349. doi: 10.15326/jcopdf.2021.0215.
8
Coding of COPD Exacerbations and the Implications on Clinical Practice, Audit and Research.慢性阻塞性肺疾病加重的编码及对临床实践、审核和研究的影响。
COPD. 2020 Dec;17(6):706-710. doi: 10.1080/15412555.2020.1841745. Epub 2020 Nov 10.
9
Preserved Ratio Impaired Spirometry in a Spirometry Database.肺量计数据库中比值保留的肺量计功能障碍。
Respir Care. 2021 Jan;66(1):58-65. doi: 10.4187/respcare.07712. Epub 2020 Sep 1.
10
Effect of Sustained-Release Morphine for Refractory Breathlessness in Chronic Obstructive Pulmonary Disease on Health Status: A Randomized Clinical Trial.持续释放吗啡治疗慢性阻塞性肺疾病难治性呼吸困难对健康状况的影响:一项随机临床试验。
JAMA Intern Med. 2020 Oct 1;180(10):1306-1314. doi: 10.1001/jamainternmed.2020.3134.

COPD 患者参加姑息治疗试验的纳入标准:系统评价。

Criteria for Enrollment of Patients With COPD in Palliative Care Trials: A Systematic Review.

机构信息

Division of Pulmonary, Allergy and Critical Care Medicine (N.S.), Emory University School of Medicine, Atlanta, Georgia, USA.

Division of Pulmonary Sciences and Critical Care Medicine (A.V.L.), University of Colorado School of Medicine, Aurora, Colorado, USA.

出版信息

J Pain Symptom Manage. 2024 Jun;67(6):e891-e905. doi: 10.1016/j.jpainsymman.2024.01.028. Epub 2024 Jan 26.

DOI:10.1016/j.jpainsymman.2024.01.028
PMID:38280439
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11088983/
Abstract

CONTEXT

Use of palliative care interventions in chronic obstructive pulmonary disease (COPD) has increased in recent years and inclusion criteria used to identify patients with COPD appropriate for palliative care vary widely. We evaluated the inclusion criteria to identify ways to improve enrollment opportunities for patients with COPD.

OBJECTIVES

To determine inclusion criteria used to select patients with COPD for palliative care trials.

METHODS

A systematic review was conducted to determine criteria used to select patients with COPD for palliative care randomized controlled trials. A narrative synthesis was conducted for all trials.

RESULTS

Inclusion criteria were highly heterogeneous. Most studies (n = 11, 79%) used a combination of criteria to identify patients with COPD. Commonly used criteria included hospitalization for an acute exacerbation of COPD (n = 8, 57%), home supplemental oxygen use (n = 8, 57%), and spirometry values confirming COPD (n = 6, 43%). Three studies (21.4%) used Modified Medical Research Council score and two studies (21%) used physician prognosis or a performance scale.

CONCLUSION

The most common criteria, a hospitalization for acute exacerbation of COPD or supplemental oxygen use at home, both have the benefit of selecting patients who have a higher symptom burden or higher healthcare utilization who might therefore benefit more from palliative care. By describing the landscape and variability of previously used inclusion criteria, this article serves as a resource for clinicians and researchers. Developing a consistent set of inclusion criteria in the future would help generate generalizable results that can be translated into clinical practice to improve the lives of patients with COPD.

PROSPERO REGISTRATION NUMBER

CRD42022306752.

摘要

背景

近年来,在慢性阻塞性肺疾病(COPD)中使用姑息治疗干预措施的情况有所增加,用于识别适合姑息治疗的 COPD 患者的纳入标准差异很大。我们评估了纳入标准,以寻找改善 COPD 患者入组机会的方法。

目的

确定用于识别 COPD 患者接受姑息治疗试验的纳入标准。

方法

进行了系统评价,以确定用于选择 COPD 患者接受姑息治疗随机对照试验的标准。对所有试验进行了叙述性综合分析。

结果

纳入标准高度异质。大多数研究(n=11,79%)使用了多种标准来识别 COPD 患者。常用的标准包括因 COPD 急性加重而住院(n=8,57%)、家庭补充氧气使用(n=8,57%)和确认 COPD 的肺功能检查值(n=6,43%)。三项研究(21.4%)使用了改良医学研究委员会评分,两项研究(21%)使用了医生预后或表现量表。

结论

最常见的标准,即因 COPD 急性加重而住院或在家中使用补充氧气,都有选择症状负担较高或医疗保健利用率较高的患者的好处,这些患者可能因此从姑息治疗中获益更多。通过描述以前使用的纳入标准的情况和可变性,本文为临床医生和研究人员提供了资源。未来制定一套一致的纳入标准将有助于产生可推广的结果,这些结果可以转化为临床实践,以改善 COPD 患者的生活。

PROSPERO 注册号:CRD42022306752。